George M Jenkins insider trades
Open-market stock purchases and sales by George M Jenkins, Director at Palvella Therapeutics, Inc, from SEC Form 4 filings since Dec 13, 2024.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -11%.
Companies traded
- PVLA Palvella Therapeutics, Inc: 5 buys, last Jun 10, 2026